Literature DB >> 30129874

Improving Rehabilitative Care of Methamphetamine Users in Germany: The Expert's Perspective.

Laura Hoffmann1, Lisa Buchenauer1, Nadine Schumann1, Sara Lena Schröder1, Olaf Martin1, Matthias Richter1.   

Abstract

Methamphetamine is one of the most frequently used drugs worldwide. In Germany, methamphetamine use has greatly increased in recent years, presenting the rehabilitative treatment system with new challenges. In this study, we identified deficits and possibilities for optimization in the field of medical rehabilitation. A total of 39 interviews and two focus groups with experts along the treatment course of methamphetamine users were conducted. Our analyses indicate that methamphetamine users are more difficult to treat compared with patients who consume other drugs. They are more likely to be associated with problematic characteristics and behaviors than other rehabilitants. Several health care deficits were revealed: too short rehabilitation treatment, no specific or differentiated therapy concepts, lack of capacity for education and vocational training, lack of outpatient options, and insufficient facilities for parents and children. Findings indicate that inadequate rehabilitation is being provided for methamphetamine users in Germany, indicating a need to adapt treatment for this group.

Entities:  

Keywords:  Germany; addiction; expert interviews; quality of care; rehabilitation; substance use

Mesh:

Substances:

Year:  2018        PMID: 30129874     DOI: 10.1177/1049732318792504

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  1 in total

1.  Treatment outcome, cognitive function, and psychopathology in methamphetamine users compared to other substance users.

Authors:  Nina Behle; Felicia Kamp; Lisa Proebstl; Laura Hager; Marlies Riebschläger; Maik Schacht-Jablonowsky; Willem Hamdorf; Stefanie Neumann; Daniela Krause; Kirsi Manz; Andreas Guenter Franke; Gabriele Koller; Michael Soyka
Journal:  World J Psychiatry       Date:  2022-07-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.